SFI
DNA icon

Susquehanna Fundamental Investments’s Ginkgo Bioworks DNA Stock Holding History

Susquehanna Fundamental Investments’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-182,925
Closed -$2.06M – 613
2025
Q2 		$2.06M Hold
182,925
– – 0.06% 331
2025
Q1 		$1.04M Hold
182,925
– – 0.01% 680
2024
Q4 		$1.8M Buy
+182,925
New +$1.57M 0.03% 553

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna Fundamental Investments's DNA Position: Q3 2025 in Review

Susquehanna Fundamental Investments sold out of Ginkgo Bioworks (DNA) in Q3 2025, closing a stake of 182,925 shares — an estimated $2.06M sold.

Susquehanna Fundamental Investments first reported a position in DNA in Q4 2024 and held it in 3 quarters. The position peaked at $2.06M in Q2 2025. 173 funds tracked by Wall St. Rank hold DNA as of Q3 2025.

  • Susquehanna Fundamental Investments reported no remaining Ginkgo Bioworks position as of Q3 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 182,925 Ginkgo Bioworks shares in Q3 2025, an estimated $2.06M.
  • Susquehanna Fundamental Investments first reported a position in Ginkgo Bioworks in Q4 2024 and held it in 3 quarters.
  • Susquehanna Fundamental Investments's Ginkgo Bioworks position peaked at $2.06M in Q2 2025.
  • 173 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2025, filed 14 Nov 2025.